Ontvang nu dagelijks onze kooptips!

word abonnee
IEX 25 jaar
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
Markt vandaag Koersen Forum Premium IEX Expert
Home  /   Forum   /   Esperite (voorheen Cryo Save)   /   Esperite 2019: het einde in zicht?

Esperite (voorheen Cryo Save)« Terug naar discussie overzicht

Esperite 2019: het einde in zicht?

Volgen
2.946 Posts
Pagina: «« 1 ... 28 29 30 31 32 ... 148 »» | Laatste | Omlaag ↓
  17. forum rang 10 DeZwarteRidder 26 februari 2019 18:36
    ESPERITE (ESP) announces private placement of convertible loan notes to the European Select Growth Opportunities Fund

    Amsterdam, The Netherlands – 26 February 2019

    Esperite N.V. (Euronext: ESP, “Esperite”) announces today a EUR 280,000 private placement of 28 convertible notes with a principal amount of EUR 10,000 each (the “Notes”), with 1,086,206 share subscription warrants attached with a strike price of EUR 0.116 (the “Warrants”). The Notes and Warrants were issued to European Select Growth Opportunities Fund, a fund based in Australia (the “Investor”).

    The placement of the Notes and Warrants is the 25th tranche launched under the issuance agreement entered into by Esperite with the Investor on 8 March 2017 (the “Issuance Agreement”). The characteristics of the Notes and the Warrants are described in Esperite’s press release of 8 March 2017. The conversion price of the Notes may not be below the nominal value of the shares, i.e. EUR 0.10 currently. As of today, EUR 8,680,000 of Notes out of the total commitment of EUR 9 million have been issued to the Investor, leaving EUR 320,000 still available for issuance by Esperite.

    As announced on 19 June 2018, Esperite has entered into a second issuance agreement with the Investor pursuant to which the Investor has committed to subscribe for an additional amount of up to EUR 5 million of convertible notes with share subscription warrants attached, subject to fulfilment of certain conditions (the “New Issuance Agreement”). The conditions are set out in the appendix to Esperite’s press release of 19 June 2018.

    On 8 January 2019, the general meeting of Esperite delegated to the Board of Directors the powers to issue such number of shares as may be required in relation to the conversion of notes and exercise of warrants in accordance with the terms of the New Issuance Agreement and restrict or exclude the pre-emptive rights in connection with such issue of shares.

    On 22 February 2019, the authorised share capital of Esperite was increased from EUR 4,800,000 (corresponding to 48,000,000 shares of EUR 0.10 each) to EUR 17,500,000 (corresponding to 175,000,000 shares of EUR 0.10 each) in relation to the New Issuance Agreement.
  19. forum rang 10 DeZwarteRidder 26 februari 2019 18:41
    Esperite heeft dus heel stiekem (want het stond niet op de agenda) het maatschappelijk kapitaal verhoogd van 48 miljoen naar 175 miljoen stuks.

    Ik ken geen enkel beursgenoteerd bedrijf dat zoveel regels overtreedt en dat op zo'n smerige manier de kleine aandeelhouders belazert en voor de gek houdt.
  20. [verwijderd] 26 februari 2019 19:29
    quote:

    DeZwarteRidder schreef op 26 februari 2019 18:36:

    (..)

    On 8 January 2019, the general meeting of Esperite delegated to the Board of Directors the powers to issue such number of shares as may be required in relation to the conversion of notes and exercise of warrants in accordance with the terms of the New Issuance Agreement and restrict or exclude the pre-emptive rights in connection with such issue of shares.

    On 22 February 2019, the authorised share capital of Esperite was increased from EUR 4,800,000 (corresponding to 48,000,000 shares of EUR 0.10 each) to EUR 17,500,000 (corresponding to 175,000,000 shares of EUR 0.10 each) in relation to the New Issuance Agreement.

    Esperite heeft dus keurig toestemming gevraagd EN gekregen op de algemene vergadering van aandeelhouders. (je mag je wel afvragen of ze dat ook -direkt na de AVA- publiekelijk bekend hebben gemaakt)
2.946 Posts
Pagina: «« 1 ... 28 29 30 31 32 ... 148 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Markt Vandaag

Stijgers

instrument koers absoluut verschil relatief verschil
BAM 4,192 +0,20 +5,06%
EBUSCO HOLDING 1,097 +0,04 +3,61%
Vastned 21,400 +0,70 +3,38%
Nedap N.V. 54,000 +1,40 +2,66%
ASML 703,400 +15,40 +2,24%
ASMI 551,600 +11,40 +2,11%
UMG 24,900 +0,49 +2,01%
AZERION 1,004 +0,01 +1,41%
Accsys 0,561 +0,01 +1,26%
CTP 15,120 +0,16 +1,07%
HEIJMANS KON 31,000 +0,30 +0,98%
BESI 128,500 +1,20 +0,94%
Eurocommercial Properties 22,450 +0,20 +0,90%
TomTom 5,450 +0,04 +0,83%
Air France-KLM 7,980 +0,06 +0,73%
NSI 19,320 +0,12 +0,63%
JUST EAT TAKEAWAY 14,640 +0,09 +0,62%
ASCX 1.234,15 +7,15 +0,58%
ADYEN NV 1.503,000 +7,80 +0,52%
Sif Holding 11,760 +0,06 +0,51%
Arcadis 60,650 +0,25 +0,41%
PROSUS 40,350 +0,13 +0,32%
RELX 44,920 +0,04 +0,09%
AMG Critical Materials N.V. 13,820 0,00 0,00%
Corbion 21,720 0,00 0,00%
NX FILTRATION 3,210 0,00 0,00%

Dalers

instrument koers absoluut verschil relatief verschil
JDE PEET'S 16,990 -1,16 -6,39%
CM.COM 5,370 -0,23 -4,11%
Kendrion 10,140 -0,32 -3,06%
ArcelorMittal 22,910 -0,70 -2,96%
Pharming 0,828 -0,02 -2,88%
Philips Koninklijke 23,830 -0,69 -2,81%
ForFarmers 3,370 -0,08 -2,32%
Aegon 5,616 -0,13 -2,26%
TKH 30,240 -0,70 -2,26%
Fugro 16,150 -0,37 -2,24%
Akzo Nobel 56,880 -1,20 -2,07%
Alfen N.V. 11,820 -0,24 -1,99%
Van Lanschot Kempen NV 43,200 -0,85 -1,93%
SHELL PLC 29,430 -0,55 -1,82%
SBM Offshore 16,390 -0,25 -1,50%
RANDSTAD NV 40,600 -0,61 -1,48%
IMCD 144,150 -2,05 -1,40%
FASTNED 21,500 -0,30 -1,38%
KPN 3,567 -0,05 -1,36%
Basic-Fit 20,940 -0,28 -1,32%
SIGNIFY NV 21,200 -0,28 -1,30%
PostNL 1,013 -0,01 -1,27%
Flow Traders 22,320 -0,22 -0,98%
ASR Nederland 44,400 -0,43 -0,96%
ING 14,692 -0,13 -0,88%
EXOR NV 89,250 -0,75 -0,83%
NN Group 41,870 -0,34 -0,81%
B&S Group SA 4,315 -0,03 -0,80%
Heineken 69,740 -0,56 -0,80%
INPOST 16,190 -0,13 -0,80%
Galapagos 25,500 -0,20 -0,78%
AMX 841,33 -6,35 -0,75%
Vopak 42,100 -0,30 -0,71%
DSM FIRMENICH AG 100,050 -0,70 -0,69%
ACOMO 17,300 -0,12 -0,69%
Brunel 8,730 -0,06 -0,68%
OCI 10,650 -0,07 -0,65%
ABN AMRO BANK N.V. 14,485 -0,10 -0,65%
Wereldhave 13,620 -0,08 -0,58%
Sligro 10,540 -0,06 -0,57%
Aperam 25,700 -0,14 -0,54%
ALLFUNDS GROUP 5,265 -0,03 -0,47%
Ahold Delhaize 31,930 -0,14 -0,44%
THEON INTERNAT 10,920 -0,04 -0,36%
Fagron 18,320 -0,06 -0,33%
UNILEVER PLC 56,340 -0,16 -0,28%
Avantium 1,756 0,00 -0,23%
RENEWI 9,690 -0,02 -0,21%
AEX 889,66 -1,82 -0,20%
Wolters Kluwer 163,700 -0,20 -0,12%
AALBERTS NV 35,000 -0,04 -0,11%
WDP 19,260 -0,02 -0,10%
vlag naam koers verschil relatief verschil
AEX 889,66 -1,82 -0,20%
AEX GR 3.489,54 -7,14 -0,20%
Germany40^ 20.242,70 -3,67 -0,02%
FTSE 100 8.195,20 -66,85 -0,81%
EURO50 4.942,53 0,00 0,00%
US30^ 43.426,80 0,00 0,00%
Nasd100^ 21.984,20 0,00 0,00%
US500^ 6.047,31 0,00 0,00%
Japan225^ 39.275,90 0,00 0,00%
VD-NEW 13,70 -0,08 -0,55%
#/^ Index indications calculated real time, zie disclaimer